WebApr 12, 2024 · 5 analysts have issued 12-month price objectives for Recursion Pharmaceuticals' stock. Their RXRX share price forecasts range from $8.00 to $20.00. On … WebRecursion Pharmaceuticals is an automated drug discovery platform. The company combines experimental biology, automation, and artificial intelligence in a parallel system …
Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (…
WebApr 14, 2024 · Esperion Therapeutics Inc (ESPR) stock is trading at $1.21 as of 11:29 AM on Friday, Apr 14, a drop of -$0.14, or -10.37% from the previous closing price of $1.35. The stock has traded between $1.21 and $1.35 so far today. Volume today is light. So far 949,750 shares have traded compared to average volume of 6,452,500 shares. WebMar 31, 2024 · RECURSION PHARMACEUTICALS, INC. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information Nasdaq: RXRX Nasdaq RECURSION PHARMACEUTICALS, INC. eer40 ボビン
Recursion Pharmaceuticals - Crunchbase Company Profile
WebJul 13, 2024 · SALT LAKE CITY, July 13, 2024 - Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, today announced its formation of a Therapeutics Advisory Board (TAB), chaired by Joseph Miletich, MD, PhD. … WebFeb 17, 2024 · Recursion Pharmaceuticals completed its IPO in 2024, raising >$500m. The company is promising to revolutionize drug discovery with AI - although the evidence for … WebApr 11, 2024 · The 15 analysts offering price forecasts for Recursion Pharmaceuticals, have a median target of 19.93, with a high estimate of 37.00 and a low estimate of 7.00. The median estimate represents a... eeprom データ化け 原因